Mark your calendars for Thursday 31st October 2024, as Regeneron Pharmaceuticals (NASDAQ: REGN) is set to unveil its third quarter financial results. This highly anticipated announcement will be made before market open, giving investors and market participants a chance to assess the company's financial performance.
According to financial analysts on Wall Street, the concern is likely to announce an estimated per share $11.69 profit for the quarter. Additionally, the company is anticipated to reveal a total revenue of $3.67 billion during this period.
Wall Street analysts have unveiled their forecasts for the company's yearly performance, estimating a total revenue of $14.17 billion. Additionally, they expect the company to reach profit of $44.77 per share for the fiscal year.
In the corresponding quarter of the previous year, the company's earnings report unveiled a per-share income of $11.59. Notably, the company's total revenue reached an impressive $3.36 billion during that specific period.
Additionally, The company will host a conference call with investors and analysts on 31st October 2024 at 08:30 AM eastern time to review the Q3 2024 financial results.
Regeneron Pharmaceuticals (REGN) closed Tuesday's regular trading session at $927.33, marking a 0.14 percent drop. The stock fluctuated between $923.75 and $932.38 during the day, with a volume of 680.40 thousand shares.
